Peter P. Toth, MD, PhD, FACC

General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Kowa(SIGNIFICANT), Theravance, Inc.(MODEST), Amarin(MODEST) SPEAKER'S BUREAU: Merck(SIGNIFICANT), Amgen(SIGNIFICANT), Novo-Nordisk(SIGNIFICANT), Esperion(SIGNIFICANT)

View Full Disclosure